Search research articles
Contact Us
Filters
Showing results (161-170 of 539) with videos related to
Page
of 54
Sort By:
Leukemia
|
May 17, 2019
Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m<sup>2</sup> vs. twice-weekly 27 mg/m<sup>2</sup> carfilzomib (randomized A.R.R.O.W. study)
Philippe Moreau, Shaji Kumar, Ralph Boccia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 22, 2007
Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis
Arnt V Kristen, Jolanta B Perz, Stefan O Schonland, et al.
Oncotarget
|
October 6, 2017
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial
Jonathan P GroΔ, Johanna Nattenmüller, Stefan Hemmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2018
Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
David S Siegel, Meletios A Dimopoulos, Heinz Ludwig, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 10, 2015
Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalities
Christos Sachpekidis, Jennifer Mosebach, Martin T Freitag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Current Oncology (Toronto, Ont.)
|
July 25, 2022
Quality of Online Information on Multiple Myeloma Available for Laypersons
Henrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Cancer
|
April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients
Leopold Sellner, Christiane Heiss, Axel Benner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple Myeloma
Felix Krummradt, Sandra Sauer, Petra Pavel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2011
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma
Brigitte Neuber, Isabelle Herth, Claudia Tolliver, et al.
Page
of 54
Search research articles
Search
Showing results (161-170 of 539) with videos related to
Sort By:
Page
of 54
Leukemia
|
May 17, 2019
Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m<sup>2</sup> vs. twice-weekly 27 mg/m<sup>2</sup> carfilzomib (randomized A.R.R.O.W. study)
Philippe Moreau, Shaji Kumar, Ralph Boccia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 22, 2007
Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis
Arnt V Kristen, Jolanta B Perz, Stefan O Schonland, et al.
Oncotarget
|
October 6, 2017
Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial
Jonathan P GroΔ, Johanna Nattenmüller, Stefan Hemmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 18, 2018
Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
David S Siegel, Meletios A Dimopoulos, Heinz Ludwig, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
November 10, 2015
Application of (18)F-FDG PET and diffusion weighted imaging (DWI) in multiple myeloma: comparison of functional imaging modalities
Christos Sachpekidis, Jennifer Mosebach, Martin T Freitag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 23, 2013
Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load
Kai Neben, Anna Jauch, Thomas Hielscher, et al.
Current Oncology (Toronto, Ont.)
|
July 25, 2022
Quality of Online Information on Multiple Myeloma Available for Laypersons
Henrike Staemmler, Sandra Sauer, Emma Pauline Kreutzer, et al.
Cancer
|
April 12, 2013
Autologous retransplantation for patients with recurrent multiple myeloma: a single-center experience with 200 patients
Leopold Sellner, Christiane Heiss, Axel Benner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 20, 2020
Storage, Utilization, and Disposal of Hematopoietic Stem Cell Products in Patients with Multiple Myeloma
Felix Krummradt, Sandra Sauer, Petra Pavel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 17, 2011
Lenalidomide enhances antigen-specific activity and decreases CD45RA expression of T cells from patients with multiple myeloma
Brigitte Neuber, Isabelle Herth, Claudia Tolliver, et al.
Page
of 54